PuSH - Publikationsserver des Helmholtz Zentrums München

Thirumoorthy, C.* ; Sharma, K.K.* ; Deepa, M.* ; Prabhu, Y.* ; Sneha, J.* ; Rekha, R.P.* ; Venkatesan, U.* ; Hemavathy, S.* ; Nikhil, J.* ; Srikumar, B.N.* ; Binukumar, B.* ; Venkatesan, R.* ; Sharma, S. ; Grallert, H. ; Ball, G.* ; Ram, U.* ; Anjana, R.M.* ; Balasubramanyam, M.* ; Tandon, N.* ; Mohan, V.* ; Saravanan, P.* ; Gokulakrishnan, K.*

Epigenome-wide association study identifies a specific panel of DNA methylation signatures for antenatal and postpartum depressive symptoms.

J. Affect. Disord. 383, 195-206 (2025)
DOI PMC
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Depression during pregnancy and postpartum poses significant risks to both maternal and child well-being. The underlying biological mechanisms are unclear, but epigenetic variation could be exploited as a plausible candidate for early detection. We investigated whether DNA methylation signatures are associated with antenatal depressive symptoms (ADS) and whether early alterations in methylation patterns could be used to predict postpartum depressive symptoms (PDS). 201 pregnant women in early pregnancy, without a prior history of depression disorders, from the STratification of Risk of Diabetes in Early Pregnancy study were recruited. Using the Patient Health Questionnaire-9 (PHQ-9), 92 women were identified with ADS, while 109 served as controls. Edinburgh Postnatal Depression Scale (EPDS) was used to assess PDS during 6-12 weeks after delivery. The dataset was split into 80 % for training and testing and 20 % for validation, to discern potential CpGs for ADS using a support vector machine classifier. Analysis revealed 591 CpGs significantly associated with ADS, from which a panel of 7 CpGs was identified to discriminate between ADS and controls with high sensitivity and specificity (AUC: 0.85 in test, 0.73 in validation). Pathway analysis highlighted involvement in inositol phosphate metabolism, notch, and calcium signaling. The same 7 CpGs predicted PDS with an AUC of 0.76 (95 % CI: 0.66-0.87). Integration of CpG data with patient-reported information significantly enhanced PDS prediction. Our study identified DNA methylation signatures that could potentially differentiate ADS from controls and predict PDS. This suggests potential for developing a CpG panel for diagnostic and preventive strategies for perinatal depression.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
Schlagwörter Antenatal Depressive Symptoms ; Dna Methylation ; Epigenome-wide Association Studies (ewas) ; Machine Learning ; Postpartum Depressive Symptoms; Receptor Gene Nr3c1; Frontal-cortex; Postnatal Depression; Pregnancy; Cortisol; Package; India
ISSN (print) / ISBN 0165-0327
e-ISSN 1573-2517
Quellenangaben Band: 383, Heft: , Seiten: 195-206 Artikelnummer: , Supplement: ,
Verlag Elsevier
Verlagsort Radarweg 29, 1043 Nx Amsterdam, Netherlands
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Epidemiology (EPI)
Förderungen
Department of Health Research (DHR), Govt. of India
Indian Council of Medical Research (ICMR)
MRC-DBT Newton fund
DBT-Wellcome Trust India Alliance
DBT-Wellcome Trust India Alliance Intermediate Clinical & Public health Fellowship